- Home
- BACC vs LRMR Comparison
BACC vs LRMR Comparison
Compare BACC & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.00
Company Overview
Basic Information| Metric | BACC | LRMR |
|---|---|---|
| Founded | 2025 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.9M | 332.1M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | BACC | LRMR |
|---|---|---|
| Price | $10.25 | $4.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.71 |
| AVG Volume (30 Days) | 71.4K | ★ 1.4M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.95 | $1.61 |
| 52 Week High | $10.44 | $5.37 |
Technical Indicators
Market Signals| Indicator | BACC | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.93 |
| Support Level | N/A | $3.34 |
| Resistance Level | N/A | $4.04 |
| Average True Range (ATR) | 0.00 | 0.26 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 80.25 |
Price Performance
Historical Comparison BACC
LRMR
About BACC Blue Acquisition Corp. Class A Ordinary Shares
Blue Acquisition Corp is a blank check company.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.